Psychosis in body dysmorphic disorder

Journal of Psychiatric Research

Volumn 38, Issue 1, 2004, Pages 63-72

  Phillips, Katharine A ^a  

^a BUTLER HOSPITAL   (United States)

Author keywords

Body Dysmorphic Disorder; Classification; Delusional disorder; Delusions; Dysmorphophobia; Psychosis

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; CLOMIPRAMINE; DESIPRAMINE; FLUOXETINE; FLUVOXAMINE; HALOPERIDOL; NEUROLEPTIC AGENT; NORTRIPTYLINE; OLANZAPINE; PIMOZIDE; SEROTONIN UPTAKE INHIBITOR; TRANYLCYPROMINE;

ANOREXIA NERVOSA; AUDITORY HALLUCINATION; BIPOLAR DISORDER; BODY DYSMORPHIC DISORDER; CLINICAL TRIAL; CONFERENCE PAPER; DELUSIONAL DISORDER; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE SEVERITY; DRUG EFFICACY; HOSTILITY; HUMAN; HYPOCHONDRIASIS; MAJOR DEPRESSION; MENTAL STRESS; MOOD DISORDER; OBSESSIVE COMPULSIVE DISORDER; PRIORITY JOURNAL; PSYCHOSIS; QUALITY OF LIFE; RATING SCALE; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SOMATOFORM DISORDER;

EID: 0347511633     PISSN: 00223956     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3956(03)00098-0     Document Type: Conference Paper

References (53)

1. Albertini R.S., Phillips K.A. 33 cases of body dysmorphic disorder in children and adolescents. Journal of the American Academy of Child and Adolescent Psychiatry. 38:1999;453-459.
2. Amador X.F., Strauss D.H., Yale S.A., Flaum M.M., Endicott J., Gorman J.M. Assessment of insight in psychosis. American Journal of Psychiatry. 150:1993;873-879.
3. Diagnostic and statistical manual of mental disorders. 3rd ed. 1987;American Psychiatric Association, Washington (DC).
4. Diagnostic and statistical manual of mental disorders. 4th ed:1994;American Psychiatric Association, Washington (DC).
5. Birtchnell S.A. Dysmorphophobia - a centenary discussion. British Journal of Psychiatry. 153(suppl 2):1988;41-43.
6. de Leon J., Bott A., Simpson G.M. Dysmorphophobia. body dysmorphic disorder or delusional disorder, somatic subtype? Comprehensive Psychiatry. 30:1989;457-472.
7. DeMarco L.M., Li L.C., Phillips K.A., McElroy S.L. Perceived stress in body dysmorphic disorder. Journal of Nervous and Mental Disease. 186:1998;724-726.
8. Eisen J.L., Phillips K.A., Baer L., Beer D.A., Atala K.D., Rasmussen S.A. The Brown Assessment of Beliefs Scale. reliability and validity American Journal of Psychiatry. 155:1998;102-108.
9. Eisen JL, Phillips KA, Coles ME, Rasmussen, SA. Insight in obsessive compulsive disorder and body dysmorphic disorder. Comprehensive Psychiatry, in press.
10. Eisen J.L., Rasmussen S.A. Obsessive compulsive disorder with psychotic features. Journal of Clinical Psychiatry. 54:1993;373-379.
11. Eisen J.L., Rasmussen S.A., Phillips K.A., Price L.H., Davidson J., Lydiard R.B.et al. Insight and treatment outcome in obsessive-compulsive disorder. Comprehensive Psychiatry. 42:2001;494-497.
12. Fernando N. Monosymptomatic hypochondriasis treated with a tricyclic antidepressant. British Journal of Psychiatry. 152:1988;851-852.
13. First M.B., Spitzer R.L., Gibbon M., Williams J.B.W. Structured Clinical Interview for DSM-IV Axis I Disorders - Patient Edition (SCID-I/P). 1996;Biometrics Research Department, New York.
14. Foa E.B., Jenike M., Kozak M.L., Joffe R., Baer L., Pauls D.et al. Obsessive-compulsive disorder. Widiger T.A., Frances A.J., Pincus H.A., Ross R., First M.B., Davis W.W. DSM-IV Sourcebook: Vol. 2. 1996;549-576 American Psychiatric Association, Washington (DC).
15. Garety P.A., Helmsley D.R. Characteristics of delusional experience. European Archives of Psychiatry and Neurological Science. 236:1987;294-298.
16. Grant J.E. Successful treatment of nondelusional body dysmorphic disorder with olanzapine. a case report Journal of Clinical Psychiatry. 62:2001;297-298.
17. Grant J.E., Won Kim S., Eckert E.D. Body dysmorphic disorder in patients with anorexia nervosa. prevalence, clinical features, and delusionality of body image International Journal of Eating Disorders. 32:2002;291-300.
18. Hollander E., Allen A., Kwon J., Aronowitz B., Schmeidler J., Wong C.et al. Clomipramine vs desipramine crossover trial in body dysmorphic disorder. Archives of General Psychiatry. 56:1999;1033-1039.
19. Hollander E., Liebowitz M.R., Winchel R., Klumker A., Klein D.F. Treatment of body-dysmorphic disorder with serotonin reuptake blockers. American Journal of Psychiatry. 146:1989;768-770.
20. Hyman S.E. Foreward. Phillips K.A., First M.B., Pincus H. Advancing DSM: dilemmas in psychiatric diagnosis. 2003;American Psychiatric Publishing, Washington (DC).
21. Insel T.R., Akiskal H. Obsessive-compulsive disorder with psychotic features. a phenomenologic analysis American Journal of Psychiatary. 12:1986;1527-1533.
22. Jenike M.A. A case report of successful treatment of dysmorphophobia with tranylcypromine. American Journal of Psychiatry. 141:1984;1463-1464.
23. Kendler K.S., Glazer W.M., Morgenstern H. Dimensions of delusional experience. American Journal of Psychiatry. 140:1983;466-469.
24. Kozak M.J., Foa E.B. Obsessions, overvalued ideas, and delusions in obsessive-compulsive disorder. Behavior Research and Therapy. 32:1994;343-353.
25. Ladee G.A. Hypochondriacal syndromes. 1996;Elsevier Publishing Company, Amsterdam.
26. Lelliott P.T., Marks I. Management of obsessive compulsive rituals associated with delusions, hallucinations, and depression. a case report Behavioral Psychotherapy. 15:1987;77-87.
27. Lelliott P.T., Noshirvani H.F., Basoglu M., Marks I.M., Monteiro W.O. Obsessive-compulsive beliefs and treatment outcome. Psychological Medicine. 18:1988;697-702.
28. Livesely W.J. Diagnostic dilemmas in the classification of personality disorder. Phillips K.A., First M.B., Pincus H. Advancing DSM: dilemmas in psychiatric diagnosis. 2003;American Psychiatric Publishing, Washington (DC).
29. McDougle C.J., Goodman W.K., Leckman J.F., Lee N.C., Heninger G.R., Price L.H. Haloperidol addition in fluvoxamine-refractory obsessive-compulsive disorder. A double-blind, placebo-controlled study in patients with and without tics. Archives of General Psychiatry. 51:1994;302-308.
30. McKenna P.J. Disorders with overvalued ideas. British Journal of Psychiatry. 145:1984;579-585.
31. Phillips K.A. Body dysmorphic disorder. the distress of imagined ugliness American Journal of Psychiatry. 148:1991;1138-1149.
32. Phillips K.A. The broken mirror: understanding and treating body dysmorphic disorder. 1996;Oxford University Press, New York.
33. Phillips KA. Delusional vs nondelusional body dysmorphic disorder. Poster Presentations and Abstracts, Brown Brain Science Research Day. Providence: Brown University School of Medicine; 1997.
34. Phillips K.A. Quality of life for patients with body dysmorphic disorder. Journal of Nervous and Mental Disease. 188:2000;170-175.
35. Phillips K.A. Pharmacologic treatment of body dysmorphic disorder. review of the evidence and a recommended treatment approach CNS Spectrums. 7:2002;453-460.
36. Phillips K.A., Albertini R.S., Rasmussen S.A. A randomized placebo-controlled trial of fluoxetine in body dysmorphic disorder. Archives of General Psychiatry. 59:2002;381-388.
37. Phillips K.A., Albertini R.S., Siniscalchi J.M., Khan A., Robinson M. Effectiveness of pharmacotherapy for body dysmorphic disorder. a chart-review study Journal of Clinical Psychiatry. 62:2001;721-727.
38. Phillips K.A., Hollander E. Body dysmorphic disorder. Widiger T.A., Frances A.J., Pincus H.A., Ross R., First M.B., Davis W.W. DSM-IV sourcebook, vol. 2. 1996;American Psychiatric Association, Washington (DC).
39. Phillips K.A., McElroy S.L. Insight, overvalued ideation, and delusional thinking in body dysmorphic disorder. theoretical and treatment implications Journal of Nervous and Mental Disease. 181:1993;699-702.
40. Phillips K.A., McElroy S.L., Dwight M.M., Eisen J.L., Rasmussen S.A. Delusionality and response to open-label fluvoxamine in body dysmorphic disorder. Journal of Clinical Psychiatry. 62:2001;87-91.
41. Phillips K.A., McElroy S.L., Keck P.E. Jr., Pope H.G. Jr., Hudson J.I. Body dysmorphic disorder: 30 cases of imagined ugliness. American Journal of Psychiatry. 150:1993;302-308.
42. Phillips K.A., McElroy S.L., Keck P.E. Jr., Pope H.G. Jr., Hudson J.I. A comparison of delusional and nondelusional body dysmorphic disorder in 100 cases. Psychopharmacology Bulletin. 30:1994;179-186.
43. Phillips KA, McElroy SL, Siniscalchi JM. Depression, anxiety, anger, and somatic symptoms in body dysmorphic disorder. In: New Research Program and Abstracts, American Psychiatric Association 2000 Annual Meeting. Chicago: APA; 2000. p. 122.
44. Phillips K.A., Price L.H., Greenberg B.D., Rasmussen S.A. Should DSM's diagnostic groupings be changed? Phillips K.A., First M.B., Pincus H. Advancing DSM: dilemmas in psychiatric diagnosis. 2003;American Psychiatric Publishing, Washington DC.
45. Riding J., Munro A. Pimozide in the treatment of monosymptomatic hypochondriacal psychosis. Acta Psychiatrica Scandinavia. 52:1975;23-30.
46. Sachs M.H., Carpenter W.T. Jr., Strauss J.S. Recovery from delusions: three phases documented by patient's interpretation of research procedures. Archives of General Psychiatry. 30:1974;117-120.
47. Salkovskis P.M., Wernike H.M.C. Cognitive therapy of obsessive- compulsive disorder. treating treatment failures Behavioral Psychotherapy. 13:1985;243-255.
48. Schatzberg A.F., Rothschild A.J. Psychotic (delusional) major depression: should it be included as a distinct syndrome in DSM-IV? Widiger T.A., Frances A.J., Pincus H.A., Ross R., First M.B., Davis W.W. DSM-IV Sourcebook; vol. 2. 1996;127-180 American Psychiatric Association, Washington (DC).
49. Solyom L., DiNicola V.F., Phil M., Sookman D., Luchins D. Is there an obsessive psychosis? Aetiological and prognostic factors of an atypical form of obsessive-compulsive neurosis. Canadian Journal of Psychiatry. 30:1985;372-379.
50. Sondheimer A. Clomipramine treatment of delusional disorder, somatic type. Journal of the American Academy of Child and Adolescent Psychiatry. 27:1988;188-192.
51. Stekel W. Compulsion and doubt (Trans by Gutheil EA). 1949;Liverwright, New York.
52. Strauss J.S. Hallucinations and delusions as points on continua function. Archives of General Psychiatry. 21:1969;581-586.
53. Zaidens S.H. Dermatologic hypochondriasis. a form of schizophrenia Psychosomatic Medicine. 12:1950;250-253.